NCT06304571View on ClinicalTrials.gov

A Study of HC006 in Subjects With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

March 15, 2026

Study Completion Date

July 16, 2026

Conditions
Advanced Solid Tumor
Interventions
DRUG

HC006

Specified dose on specified days

Trial Locations (1)

200120

RECRUITING

Shanghai East Hospital, Shanghai

Sponsors

Lead Sponsor

HC Biopharma Inc.
All Listed Sponsors
lead

HC Biopharma Inc.

INDUSTRY